Zoster Eye Disease Study (ZEDS): A multi-center randomized double-masked placebo-controlled study of valacyclovir in immunocompetent subjects with a history of dendriform epithelial keratitis stromal keratitis endothelial keratitis and/or iritis due to Herpes Zoster Ophthalmicus (HZO) within the year prior to enrollment.

Zoster Eye Disease Study (ZEDS): A multi-center  randomized  double-masked  placebo-controlled study of valacyclovir in immunocompetent subjects with a history of dendriform epithelial keratitis  stromal keratitis  endothelial keratitis  and/or iritis due to Herpes Zoster Ophthalmicus (HZO) within the year prior to enrollment.

Brief description of study

Request to rely on the lead site IRB, see attached documents

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Herpes Zoster Ophthalmicus
  • Age: - 99 Years
  • Gender: All
Updated on 09 Mar 2024. Study ID: 827758

Find a site

What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center